Results for “ ”

Entry Author Date Location
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/21/20 Boston
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series 09/16/20 Boston
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest 09/08/20 San Francisco
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests 08/27/20 Seattle
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 07/15/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs 07/01/20 San Francisco
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Page 1 of 359 next page »